Do Ozempic (semaglutide) side effects get milder after starting?
Most people who take Ozempic for weight loss or type 2 diabetes report that common gastrointestinal (GI) side effects are most noticeable early in treatment—especially during dose increases—and then lessen as the body adjusts. This pattern matches how clinicians usually manage semaglutide: start at a low dose and increase gradually to reduce early intolerance (for example, nausea).
What side effects are usually worst at the beginning?
The side effects most often described as intense early are typically GI-related, such as:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Indigestion/heartburn
Because these effects are tied to dose and GI adaptation, intensity often drops as the dose stabilizes.
Can side effects persist or worsen over time?
Yes. Not everyone follows the “milder after adjustment” pattern. Side effects can continue, recur after a dose increase, or worsen if:
- the dose is increased too quickly for that person,
- eating patterns don’t match the medication’s effect (slower stomach emptying),
- another medication or illness contributes to GI upset.
How do dose changes affect intensity?
A common real-world driver of “why did my side effects come back?” is a dose step up. Even if symptoms were improving at the prior dose, they may flare temporarily after increasing to the next dose, then ease again as adaptation occurs.
When should someone contact a clinician urgently?
Even if side effects often lessen, patients should get prompt medical advice if they have severe or persistent symptoms, signs of dehydration (for example, from vomiting/diarrhea), or symptoms that suggest complications rather than typical GI upset.
Sources
No provided sources were included with your question, so I can’t cite specific trial- or label-based intensity-over-time data here. If you share which Ozempic indication and dose (for example, diabetes vs weight loss; 0.5 mg/1 mg/2 mg), I can give a more targeted answer using the relevant prescribing information or trial data.